Global Neurovascular Devices for Hemorrhagic Stroke Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Neurovascular Devices for Hemorrhagic Stroke is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Neurovascular Devices for Hemorrhagic Stroke market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Neurovascular Devices for Hemorrhagic Stroke market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Neurovascular Devices for Hemorrhagic Stroke market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Neurovascular Devices for Hemorrhagic Stroke market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Neurovascular Devices for Hemorrhagic Stroke players cover Stryker Corporation, Medtronic, Johnson & Johnson, Terumo and Abbott Vascular, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Neurovascular Devices for Hemorrhagic Stroke market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Neurovascular Devices for Hemorrhagic Stroke market, with both quantitative and qualitative data, to help readers understand how the Neurovascular Devices for Hemorrhagic Stroke market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Neurovascular Devices for Hemorrhagic Stroke market and forecasts the market size by Type (Support Devices and Neurothrombectomy Devices,), by Application (Hospitals and Clinics.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Neurovascular Devices for Hemorrhagic Stroke, Research Methodology, etc.
Chapter 2: Executive Summary, global Neurovascular Devices for Hemorrhagic Stroke market size (sales and revenue) and CAGR, Neurovascular Devices for Hemorrhagic Stroke market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Neurovascular Devices for Hemorrhagic Stroke sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Neurovascular Devices for Hemorrhagic Stroke sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Neurovascular Devices for Hemorrhagic Stroke market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Stryker Corporation, Medtronic, Johnson & Johnson, Terumo, Abbott Vascular, Acandis, Cerenovus, Ceres Endovascular and Imperative Care, etc.
Chapter 14: Research Findings and Conclusion
The global market for Neurovascular Devices for Hemorrhagic Stroke is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Neurovascular Devices for Hemorrhagic Stroke market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Neurovascular Devices for Hemorrhagic Stroke market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Neurovascular Devices for Hemorrhagic Stroke market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Neurovascular Devices for Hemorrhagic Stroke market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Neurovascular Devices for Hemorrhagic Stroke players cover Stryker Corporation, Medtronic, Johnson & Johnson, Terumo and Abbott Vascular, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Neurovascular Devices for Hemorrhagic Stroke market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Neurovascular Devices for Hemorrhagic Stroke market, with both quantitative and qualitative data, to help readers understand how the Neurovascular Devices for Hemorrhagic Stroke market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Neurovascular Devices for Hemorrhagic Stroke market and forecasts the market size by Type (Support Devices and Neurothrombectomy Devices,), by Application (Hospitals and Clinics.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Support Devices
- Neurothrombectomy Devices
- Hospitals
- Clinics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Stryker Corporation
- Medtronic
- Johnson & Johnson
- Terumo
- Abbott Vascular
- Acandis
- Cerenovus
- Ceres Endovascular
- Imperative Care
- Penumbra
- MicroPort Scientific
- NICO Corporation
- Phenox
- Rapid Medical
- Shape Memory Medical
- Wallaby Medical
Chapter 1: Scope of Neurovascular Devices for Hemorrhagic Stroke, Research Methodology, etc.
Chapter 2: Executive Summary, global Neurovascular Devices for Hemorrhagic Stroke market size (sales and revenue) and CAGR, Neurovascular Devices for Hemorrhagic Stroke market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Neurovascular Devices for Hemorrhagic Stroke sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Neurovascular Devices for Hemorrhagic Stroke sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Neurovascular Devices for Hemorrhagic Stroke market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Stryker Corporation, Medtronic, Johnson & Johnson, Terumo, Abbott Vascular, Acandis, Cerenovus, Ceres Endovascular and Imperative Care, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Neurovascular Devices for Hemorrhagic Stroke by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Neurovascular Devices for Hemorrhagic Stroke by Country/Region, 2017, 2022 & 2028
2.2 Neurovascular Devices for Hemorrhagic Stroke Segment by Type
2.2.1 Support Devices
2.2.2 Neurothrombectomy Devices
2.3 Neurovascular Devices for Hemorrhagic Stroke Sales by Type
2.3.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
2.3.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue and Market Share by Type (2017-2022)
2.3.3 Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Type (2017-2022)
2.4 Neurovascular Devices for Hemorrhagic Stroke Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Neurovascular Devices for Hemorrhagic Stroke Sales by Application
2.5.1 Global Neurovascular Devices for Hemorrhagic Stroke Sale Market Share by Application (2017-2022)
2.5.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue and Market Share by Application (2017-2022)
2.5.3 Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Application (2017-2022)
3 GLOBAL NEUROVASCULAR DEVICES FOR HEMORRHAGIC STROKE BY COMPANY
3.1 Global Neurovascular Devices for Hemorrhagic Stroke Breakdown Data by Company
3.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Annual Sales by Company (2020-2022)
3.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Company (2020-2022)
3.2 Global Neurovascular Devices for Hemorrhagic Stroke Annual Revenue by Company (2020-2022)
3.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Company (2020-2022)
3.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Company (2020-2022)
3.3 Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Company
3.4 Key Manufacturers Neurovascular Devices for Hemorrhagic Stroke Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurovascular Devices for Hemorrhagic Stroke Product Location Distribution
3.4.2 Players Neurovascular Devices for Hemorrhagic Stroke Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUROVASCULAR DEVICES FOR HEMORRHAGIC STROKE BY GEOGRAPHIC REGION
4.1 World Historic Neurovascular Devices for Hemorrhagic Stroke Market Size by Geographic Region (2017-2022)
4.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Annual Revenue by Geographic Region
4.2 World Historic Neurovascular Devices for Hemorrhagic Stroke Market Size by Country/Region (2017-2022)
4.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Annual Sales by Country/Region (2017-2022)
4.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Annual Revenue by Country/Region
4.3 Americas Neurovascular Devices for Hemorrhagic Stroke Sales Growth
4.4 APAC Neurovascular Devices for Hemorrhagic Stroke Sales Growth
4.5 Europe Neurovascular Devices for Hemorrhagic Stroke Sales Growth
4.6 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Growth
5 AMERICAS
5.1 Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Country
5.1.1 Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022)
5.1.2 Americas Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022)
5.2 Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Type
5.3 Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Region
6.1.1 APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2017-2022)
6.1.2 APAC Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2017-2022)
6.2 APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Type
6.3 APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurovascular Devices for Hemorrhagic Stroke by Country
7.1.1 Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022)
7.1.2 Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022)
7.2 Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Type
7.3 Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke by Country
8.1.1 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022)
8.1.2 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022)
8.2 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Type
8.3 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurovascular Devices for Hemorrhagic Stroke
10.3 Manufacturing Process Analysis of Neurovascular Devices for Hemorrhagic Stroke
10.4 Industry Chain Structure of Neurovascular Devices for Hemorrhagic Stroke
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurovascular Devices for Hemorrhagic Stroke Distributors
11.3 Neurovascular Devices for Hemorrhagic Stroke Customer
12 WORLD FORECAST REVIEW FOR NEUROVASCULAR DEVICES FOR HEMORRHAGIC STROKE BY GEOGRAPHIC REGION
12.1 Global Neurovascular Devices for Hemorrhagic Stroke Market Size Forecast by Region
12.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Forecast by Region (2023-2028)
12.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neurovascular Devices for Hemorrhagic Stroke Forecast by Type
12.7 Global Neurovascular Devices for Hemorrhagic Stroke Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Stryker Corporation
13.1.1 Stryker Corporation Company Information
13.1.2 Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.1.3 Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Stryker Corporation Main Business Overview
13.1.5 Stryker Corporation Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.2.3 Medtronic Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.3.3 Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Terumo
13.4.1 Terumo Company Information
13.4.2 Terumo Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.4.3 Terumo Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Terumo Main Business Overview
13.4.5 Terumo Latest Developments
13.5 Abbott Vascular
13.5.1 Abbott Vascular Company Information
13.5.2 Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.5.3 Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abbott Vascular Main Business Overview
13.5.5 Abbott Vascular Latest Developments
13.6 Acandis
13.6.1 Acandis Company Information
13.6.2 Acandis Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.6.3 Acandis Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Acandis Main Business Overview
13.6.5 Acandis Latest Developments
13.7 Cerenovus
13.7.1 Cerenovus Company Information
13.7.2 Cerenovus Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.7.3 Cerenovus Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Cerenovus Main Business Overview
13.7.5 Cerenovus Latest Developments
13.8 Ceres Endovascular
13.8.1 Ceres Endovascular Company Information
13.8.2 Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.8.3 Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Ceres Endovascular Main Business Overview
13.8.5 Ceres Endovascular Latest Developments
13.9 Imperative Care
13.9.1 Imperative Care Company Information
13.9.2 Imperative Care Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.9.3 Imperative Care Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Imperative Care Main Business Overview
13.9.5 Imperative Care Latest Developments
13.10 Penumbra
13.10.1 Penumbra Company Information
13.10.2 Penumbra Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.10.3 Penumbra Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Penumbra Main Business Overview
13.10.5 Penumbra Latest Developments
13.11 MicroPort Scientific
13.11.1 MicroPort Scientific Company Information
13.11.2 MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.11.3 MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 MicroPort Scientific Main Business Overview
13.11.5 MicroPort Scientific Latest Developments
13.12 NICO Corporation
13.12.1 NICO Corporation Company Information
13.12.2 NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.12.3 NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 NICO Corporation Main Business Overview
13.12.5 NICO Corporation Latest Developments
13.13 Phenox
13.13.1 Phenox Company Information
13.13.2 Phenox Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.13.3 Phenox Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Phenox Main Business Overview
13.13.5 Phenox Latest Developments
13.14 Rapid Medical
13.14.1 Rapid Medical Company Information
13.14.2 Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.14.3 Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Rapid Medical Main Business Overview
13.14.5 Rapid Medical Latest Developments
13.15 Shape Memory Medical
13.15.1 Shape Memory Medical Company Information
13.15.2 Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.15.3 Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Shape Memory Medical Main Business Overview
13.15.5 Shape Memory Medical Latest Developments
13.16 Wallaby Medical
13.16.1 Wallaby Medical Company Information
13.16.2 Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.16.3 Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Wallaby Medical Main Business Overview
13.16.5 Wallaby Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Neurovascular Devices for Hemorrhagic Stroke by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Neurovascular Devices for Hemorrhagic Stroke by Country/Region, 2017, 2022 & 2028
2.2 Neurovascular Devices for Hemorrhagic Stroke Segment by Type
2.2.1 Support Devices
2.2.2 Neurothrombectomy Devices
2.3 Neurovascular Devices for Hemorrhagic Stroke Sales by Type
2.3.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
2.3.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue and Market Share by Type (2017-2022)
2.3.3 Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Type (2017-2022)
2.4 Neurovascular Devices for Hemorrhagic Stroke Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Neurovascular Devices for Hemorrhagic Stroke Sales by Application
2.5.1 Global Neurovascular Devices for Hemorrhagic Stroke Sale Market Share by Application (2017-2022)
2.5.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue and Market Share by Application (2017-2022)
2.5.3 Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Application (2017-2022)
3 GLOBAL NEUROVASCULAR DEVICES FOR HEMORRHAGIC STROKE BY COMPANY
3.1 Global Neurovascular Devices for Hemorrhagic Stroke Breakdown Data by Company
3.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Annual Sales by Company (2020-2022)
3.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Company (2020-2022)
3.2 Global Neurovascular Devices for Hemorrhagic Stroke Annual Revenue by Company (2020-2022)
3.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Company (2020-2022)
3.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Company (2020-2022)
3.3 Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Company
3.4 Key Manufacturers Neurovascular Devices for Hemorrhagic Stroke Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurovascular Devices for Hemorrhagic Stroke Product Location Distribution
3.4.2 Players Neurovascular Devices for Hemorrhagic Stroke Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUROVASCULAR DEVICES FOR HEMORRHAGIC STROKE BY GEOGRAPHIC REGION
4.1 World Historic Neurovascular Devices for Hemorrhagic Stroke Market Size by Geographic Region (2017-2022)
4.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Annual Revenue by Geographic Region
4.2 World Historic Neurovascular Devices for Hemorrhagic Stroke Market Size by Country/Region (2017-2022)
4.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Annual Sales by Country/Region (2017-2022)
4.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Annual Revenue by Country/Region
4.3 Americas Neurovascular Devices for Hemorrhagic Stroke Sales Growth
4.4 APAC Neurovascular Devices for Hemorrhagic Stroke Sales Growth
4.5 Europe Neurovascular Devices for Hemorrhagic Stroke Sales Growth
4.6 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Growth
5 AMERICAS
5.1 Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Country
5.1.1 Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022)
5.1.2 Americas Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022)
5.2 Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Type
5.3 Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Region
6.1.1 APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2017-2022)
6.1.2 APAC Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2017-2022)
6.2 APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Type
6.3 APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurovascular Devices for Hemorrhagic Stroke by Country
7.1.1 Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022)
7.1.2 Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022)
7.2 Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Type
7.3 Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke by Country
8.1.1 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022)
8.1.2 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022)
8.2 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Type
8.3 Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurovascular Devices for Hemorrhagic Stroke
10.3 Manufacturing Process Analysis of Neurovascular Devices for Hemorrhagic Stroke
10.4 Industry Chain Structure of Neurovascular Devices for Hemorrhagic Stroke
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurovascular Devices for Hemorrhagic Stroke Distributors
11.3 Neurovascular Devices for Hemorrhagic Stroke Customer
12 WORLD FORECAST REVIEW FOR NEUROVASCULAR DEVICES FOR HEMORRHAGIC STROKE BY GEOGRAPHIC REGION
12.1 Global Neurovascular Devices for Hemorrhagic Stroke Market Size Forecast by Region
12.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Forecast by Region (2023-2028)
12.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neurovascular Devices for Hemorrhagic Stroke Forecast by Type
12.7 Global Neurovascular Devices for Hemorrhagic Stroke Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Stryker Corporation
13.1.1 Stryker Corporation Company Information
13.1.2 Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.1.3 Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Stryker Corporation Main Business Overview
13.1.5 Stryker Corporation Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.2.3 Medtronic Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.3.3 Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Terumo
13.4.1 Terumo Company Information
13.4.2 Terumo Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.4.3 Terumo Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Terumo Main Business Overview
13.4.5 Terumo Latest Developments
13.5 Abbott Vascular
13.5.1 Abbott Vascular Company Information
13.5.2 Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.5.3 Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abbott Vascular Main Business Overview
13.5.5 Abbott Vascular Latest Developments
13.6 Acandis
13.6.1 Acandis Company Information
13.6.2 Acandis Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.6.3 Acandis Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Acandis Main Business Overview
13.6.5 Acandis Latest Developments
13.7 Cerenovus
13.7.1 Cerenovus Company Information
13.7.2 Cerenovus Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.7.3 Cerenovus Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Cerenovus Main Business Overview
13.7.5 Cerenovus Latest Developments
13.8 Ceres Endovascular
13.8.1 Ceres Endovascular Company Information
13.8.2 Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.8.3 Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Ceres Endovascular Main Business Overview
13.8.5 Ceres Endovascular Latest Developments
13.9 Imperative Care
13.9.1 Imperative Care Company Information
13.9.2 Imperative Care Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.9.3 Imperative Care Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Imperative Care Main Business Overview
13.9.5 Imperative Care Latest Developments
13.10 Penumbra
13.10.1 Penumbra Company Information
13.10.2 Penumbra Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.10.3 Penumbra Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Penumbra Main Business Overview
13.10.5 Penumbra Latest Developments
13.11 MicroPort Scientific
13.11.1 MicroPort Scientific Company Information
13.11.2 MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.11.3 MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 MicroPort Scientific Main Business Overview
13.11.5 MicroPort Scientific Latest Developments
13.12 NICO Corporation
13.12.1 NICO Corporation Company Information
13.12.2 NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.12.3 NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 NICO Corporation Main Business Overview
13.12.5 NICO Corporation Latest Developments
13.13 Phenox
13.13.1 Phenox Company Information
13.13.2 Phenox Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.13.3 Phenox Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Phenox Main Business Overview
13.13.5 Phenox Latest Developments
13.14 Rapid Medical
13.14.1 Rapid Medical Company Information
13.14.2 Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.14.3 Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Rapid Medical Main Business Overview
13.14.5 Rapid Medical Latest Developments
13.15 Shape Memory Medical
13.15.1 Shape Memory Medical Company Information
13.15.2 Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.15.3 Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Shape Memory Medical Main Business Overview
13.15.5 Shape Memory Medical Latest Developments
13.16 Wallaby Medical
13.16.1 Wallaby Medical Company Information
13.16.2 Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
13.16.3 Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Wallaby Medical Main Business Overview
13.16.5 Wallaby Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurovascular Devices for Hemorrhagic Stroke Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Neurovascular Devices for Hemorrhagic Stroke Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Support Devices
Table 4. Major Players of Neurothrombectomy Devices
Table 5. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2022) & (K Units)
Table 6. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
Table 7. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2017-2022) & ($ million)
Table 8. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Type (2017-2022)
Table 9. Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2022) & (K Units)
Table 11. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Table 12. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2017-2022)
Table 13. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Application (2017-2022)
Table 14. Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Company (2020-2022) & (K Units)
Table 16. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Company (2020-2022)
Table 17. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Company (2020-2022)
Table 19. Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Neurovascular Devices for Hemorrhagic Stroke Producing Area Distribution and Sales Area
Table 21. Players Neurovascular Devices for Hemorrhagic Stroke Products Offered
Table 22. Neurovascular Devices for Hemorrhagic Stroke Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share Geographic Region (2017-2022)
Table 27. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country/Region (2017-2022)
Table 31. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022) & (K Units)
Table 34. Americas Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2017-2022)
Table 35. Americas Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2017-2022)
Table 37. Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2022) & (K Units)
Table 38. Americas Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
Table 39. Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2022) & (K Units)
Table 40. Americas Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Table 41. APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2017-2022) & (K Units)
Table 42. APAC Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region (2017-2022)
Table 43. APAC Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Region (2017-2022)
Table 45. APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2022) & (K Units)
Table 46. APAC Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
Table 47. APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2022) & (K Units)
Table 48. APAC Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Table 49. Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022) & (K Units)
Table 50. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2017-2022)
Table 51. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2017-2022)
Table 53. Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2022) & (K Units)
Table 54. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
Table 55. Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2022) & (K Units)
Table 56. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Neurovascular Devices for Hemorrhagic Stroke
Table 66. Key Market Challenges & Risks of Neurovascular Devices for Hemorrhagic Stroke
Table 67. Key Industry Trends of Neurovascular Devices for Hemorrhagic Stroke
Table 68. Neurovascular Devices for Hemorrhagic Stroke Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Neurovascular Devices for Hemorrhagic Stroke Distributors List
Table 71. Neurovascular Devices for Hemorrhagic Stroke Customer List
Table 72. Global Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Forecast by Region
Table 74. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share Forecast by Application (2023-2028)
Table 92. Stryker Corporation Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 93. Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 94. Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Stryker Corporation Main Business
Table 96. Stryker Corporation Latest Developments
Table 97. Medtronic Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 98. Medtronic Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 99. Medtronic Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Medtronic Main Business
Table 101. Medtronic Latest Developments
Table 102. Johnson & Johnson Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 103. Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 104. Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Johnson & Johnson Main Business
Table 106. Johnson & Johnson Latest Developments
Table 107. Terumo Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 108. Terumo Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 109. Terumo Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Terumo Main Business
Table 111. Terumo Latest Developments
Table 112. Abbott Vascular Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 113. Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 114. Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Abbott Vascular Main Business
Table 116. Abbott Vascular Latest Developments
Table 117. Acandis Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 118. Acandis Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 119. Acandis Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Acandis Main Business
Table 121. Acandis Latest Developments
Table 122. Cerenovus Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 123. Cerenovus Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 124. Cerenovus Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Cerenovus Main Business
Table 126. Cerenovus Latest Developments
Table 127. Ceres Endovascular Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 128. Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 129. Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Ceres Endovascular Main Business
Table 131. Ceres Endovascular Latest Developments
Table 132. Imperative Care Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 133. Imperative Care Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 134. Imperative Care Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Imperative Care Main Business
Table 136. Imperative Care Latest Developments
Table 137. Penumbra Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 138. Penumbra Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 139. Penumbra Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Penumbra Main Business
Table 141. Penumbra Latest Developments
Table 142. MicroPort Scientific Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 143. MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 144. MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. MicroPort Scientific Main Business
Table 146. MicroPort Scientific Latest Developments
Table 147. NICO Corporation Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 148. NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 149. NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. NICO Corporation Main Business
Table 151. NICO Corporation Latest Developments
Table 152. Phenox Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 153. Phenox Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 154. Phenox Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Phenox Main Business
Table 156. Phenox Latest Developments
Table 157. Rapid Medical Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 158. Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 159. Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Rapid Medical Main Business
Table 161. Rapid Medical Latest Developments
Table 162. Shape Memory Medical Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 163. Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 164. Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Shape Memory Medical Main Business
Table 166. Shape Memory Medical Latest Developments
Table 167. Wallaby Medical Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 168. Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 169. Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Wallaby Medical Main Business
Table 171. Wallaby Medical Latest Developments
Table 1. Neurovascular Devices for Hemorrhagic Stroke Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Neurovascular Devices for Hemorrhagic Stroke Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Support Devices
Table 4. Major Players of Neurothrombectomy Devices
Table 5. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2022) & (K Units)
Table 6. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
Table 7. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2017-2022) & ($ million)
Table 8. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Type (2017-2022)
Table 9. Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2022) & (K Units)
Table 11. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Table 12. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2017-2022)
Table 13. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Application (2017-2022)
Table 14. Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Company (2020-2022) & (K Units)
Table 16. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Company (2020-2022)
Table 17. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Company (2020-2022)
Table 19. Global Neurovascular Devices for Hemorrhagic Stroke Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Neurovascular Devices for Hemorrhagic Stroke Producing Area Distribution and Sales Area
Table 21. Players Neurovascular Devices for Hemorrhagic Stroke Products Offered
Table 22. Neurovascular Devices for Hemorrhagic Stroke Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share Geographic Region (2017-2022)
Table 27. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country/Region (2017-2022)
Table 31. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022) & (K Units)
Table 34. Americas Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2017-2022)
Table 35. Americas Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2017-2022)
Table 37. Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2022) & (K Units)
Table 38. Americas Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
Table 39. Americas Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2022) & (K Units)
Table 40. Americas Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Table 41. APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2017-2022) & (K Units)
Table 42. APAC Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region (2017-2022)
Table 43. APAC Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Region (2017-2022)
Table 45. APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2022) & (K Units)
Table 46. APAC Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
Table 47. APAC Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2022) & (K Units)
Table 48. APAC Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Table 49. Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022) & (K Units)
Table 50. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2017-2022)
Table 51. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2017-2022)
Table 53. Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2022) & (K Units)
Table 54. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
Table 55. Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2022) & (K Units)
Table 56. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Neurovascular Devices for Hemorrhagic Stroke
Table 66. Key Market Challenges & Risks of Neurovascular Devices for Hemorrhagic Stroke
Table 67. Key Industry Trends of Neurovascular Devices for Hemorrhagic Stroke
Table 68. Neurovascular Devices for Hemorrhagic Stroke Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Neurovascular Devices for Hemorrhagic Stroke Distributors List
Table 71. Neurovascular Devices for Hemorrhagic Stroke Customer List
Table 72. Global Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Forecast by Region
Table 74. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Neurovascular Devices for Hemorrhagic Stroke Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share Forecast by Application (2023-2028)
Table 92. Stryker Corporation Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 93. Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 94. Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Stryker Corporation Main Business
Table 96. Stryker Corporation Latest Developments
Table 97. Medtronic Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 98. Medtronic Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 99. Medtronic Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Medtronic Main Business
Table 101. Medtronic Latest Developments
Table 102. Johnson & Johnson Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 103. Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 104. Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Johnson & Johnson Main Business
Table 106. Johnson & Johnson Latest Developments
Table 107. Terumo Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 108. Terumo Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 109. Terumo Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Terumo Main Business
Table 111. Terumo Latest Developments
Table 112. Abbott Vascular Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 113. Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 114. Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Abbott Vascular Main Business
Table 116. Abbott Vascular Latest Developments
Table 117. Acandis Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 118. Acandis Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 119. Acandis Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Acandis Main Business
Table 121. Acandis Latest Developments
Table 122. Cerenovus Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 123. Cerenovus Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 124. Cerenovus Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Cerenovus Main Business
Table 126. Cerenovus Latest Developments
Table 127. Ceres Endovascular Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 128. Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 129. Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Ceres Endovascular Main Business
Table 131. Ceres Endovascular Latest Developments
Table 132. Imperative Care Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 133. Imperative Care Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 134. Imperative Care Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Imperative Care Main Business
Table 136. Imperative Care Latest Developments
Table 137. Penumbra Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 138. Penumbra Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 139. Penumbra Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Penumbra Main Business
Table 141. Penumbra Latest Developments
Table 142. MicroPort Scientific Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 143. MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 144. MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. MicroPort Scientific Main Business
Table 146. MicroPort Scientific Latest Developments
Table 147. NICO Corporation Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 148. NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 149. NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. NICO Corporation Main Business
Table 151. NICO Corporation Latest Developments
Table 152. Phenox Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 153. Phenox Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 154. Phenox Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Phenox Main Business
Table 156. Phenox Latest Developments
Table 157. Rapid Medical Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 158. Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 159. Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Rapid Medical Main Business
Table 161. Rapid Medical Latest Developments
Table 162. Shape Memory Medical Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 163. Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 164. Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Shape Memory Medical Main Business
Table 166. Shape Memory Medical Latest Developments
Table 167. Wallaby Medical Basic Information, Neurovascular Devices for Hemorrhagic Stroke Manufacturing Base, Sales Area and Its Competitors
Table 168. Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Product Offered
Table 169. Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Wallaby Medical Main Business
Table 171. Wallaby Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neurovascular Devices for Hemorrhagic Stroke
Figure 2. Neurovascular Devices for Hemorrhagic Stroke Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurovascular Devices for Hemorrhagic Stroke Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Support Devices
Figure 10. Product Picture of Neurothrombectomy Devices
Figure 11. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type in 2021
Figure 12. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Type (2017-2022)
Figure 13. Neurovascular Devices for Hemorrhagic Stroke Consumed in Hospitals
Figure 14. Global Neurovascular Devices for Hemorrhagic Stroke Market: Hospitals (2017-2022) & (K Units)
Figure 15. Neurovascular Devices for Hemorrhagic Stroke Consumed in Clinics
Figure 16. Global Neurovascular Devices for Hemorrhagic Stroke Market: Clinics (2017-2022) & (K Units)
Figure 17. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Figure 18. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Application in 2021
Figure 19. Neurovascular Devices for Hemorrhagic Stroke Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Company in 2021
Figure 21. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Geographic Region in 2021
Figure 23. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region (2017-2022)
Figure 24. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country/Region in 2021
Figure 25. Americas Neurovascular Devices for Hemorrhagic Stroke Sales 2017-2022 (K Units)
Figure 26. Americas Neurovascular Devices for Hemorrhagic Stroke Revenue 2017-2022 ($ Millions)
Figure 27. APAC Neurovascular Devices for Hemorrhagic Stroke Sales 2017-2022 (K Units)
Figure 28. APAC Neurovascular Devices for Hemorrhagic Stroke Revenue 2017-2022 ($ Millions)
Figure 29. Europe Neurovascular Devices for Hemorrhagic Stroke Sales 2017-2022 (K Units)
Figure 30. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue 2017-2022 ($ Millions)
Figure 33. Americas Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country in 2021
Figure 34. Americas Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country in 2021
Figure 35. United States Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region in 2021
Figure 40. APAC Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Regions in 2021
Figure 41. China Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country in 2021
Figure 48. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country in 2021
Figure 49. Germany Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country in 2021
Figure 56. Egypt Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Neurovascular Devices for Hemorrhagic Stroke in 2021
Figure 62. Manufacturing Process Analysis of Neurovascular Devices for Hemorrhagic Stroke
Figure 63. Industry Chain Structure of Neurovascular Devices for Hemorrhagic Stroke
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 1. Picture of Neurovascular Devices for Hemorrhagic Stroke
Figure 2. Neurovascular Devices for Hemorrhagic Stroke Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurovascular Devices for Hemorrhagic Stroke Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Support Devices
Figure 10. Product Picture of Neurothrombectomy Devices
Figure 11. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type in 2021
Figure 12. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Type (2017-2022)
Figure 13. Neurovascular Devices for Hemorrhagic Stroke Consumed in Hospitals
Figure 14. Global Neurovascular Devices for Hemorrhagic Stroke Market: Hospitals (2017-2022) & (K Units)
Figure 15. Neurovascular Devices for Hemorrhagic Stroke Consumed in Clinics
Figure 16. Global Neurovascular Devices for Hemorrhagic Stroke Market: Clinics (2017-2022) & (K Units)
Figure 17. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2017-2022)
Figure 18. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Application in 2021
Figure 19. Neurovascular Devices for Hemorrhagic Stroke Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Company in 2021
Figure 21. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Geographic Region in 2021
Figure 23. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region (2017-2022)
Figure 24. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country/Region in 2021
Figure 25. Americas Neurovascular Devices for Hemorrhagic Stroke Sales 2017-2022 (K Units)
Figure 26. Americas Neurovascular Devices for Hemorrhagic Stroke Revenue 2017-2022 ($ Millions)
Figure 27. APAC Neurovascular Devices for Hemorrhagic Stroke Sales 2017-2022 (K Units)
Figure 28. APAC Neurovascular Devices for Hemorrhagic Stroke Revenue 2017-2022 ($ Millions)
Figure 29. Europe Neurovascular Devices for Hemorrhagic Stroke Sales 2017-2022 (K Units)
Figure 30. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue 2017-2022 ($ Millions)
Figure 33. Americas Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country in 2021
Figure 34. Americas Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country in 2021
Figure 35. United States Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region in 2021
Figure 40. APAC Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Regions in 2021
Figure 41. China Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country in 2021
Figure 48. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country in 2021
Figure 49. Germany Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country in 2021
Figure 56. Egypt Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Neurovascular Devices for Hemorrhagic Stroke Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Neurovascular Devices for Hemorrhagic Stroke in 2021
Figure 62. Manufacturing Process Analysis of Neurovascular Devices for Hemorrhagic Stroke
Figure 63. Industry Chain Structure of Neurovascular Devices for Hemorrhagic Stroke
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
